TABLE 1.
Characteristics of the participants according to hypertension phenotypes defined by the studied abnormal HBPM cutoffs
Abnormal HBPM cutoff | 135/85 mmHg | 130/80 mmHg | ||||||
---|---|---|---|---|---|---|---|---|
Untreated participants | ||||||||
Phenotypes | NT | WH | MH | SH | NT | WH | MH | SH |
N | 12 775 | 4,242 | 2,664 | 7,195 | 9,530 | 1,991 | 5,909 | 9,446 |
Men, % | 38 | 41 a | 43 a | 45 a , b | 37 | 38 | 43 a , b | 45 a , b |
Age, years | 51 ± 16 | 54 ± 16 a | 55 ± 16 a | 55 ± 16 a | 51 ± 16 | 56 ± 16 a | 53 ± 16 a , b | 54 ± 16 a , b , c |
Body mass index, kg/m2 | 28.0 ± 5.1 | 28.4 ± 5.4 a | 28.8 ± 5.4 a , b | 28.9 ± 5.5 a , b | 27.8 ± 5.0 | 28.1 ± 5.4 | 28.8 ± 5.2 a , b | 28.8 ± 5.4 a , b |
Office systolic BP, mmHg | 118 ± 12 | 141 ± 14 a | 125 ± 10 a , b | 148 ± 18 a , b , c | 117 ± 12 | 142 ± 14 a | 123 ± 10 a , b | 146 ± 17 a , b , c |
Office diastolic BP, mmHg | 77 ± 8 | 91 ± 8 a | 81 ± 7 a , b | 96 ± 11 a , b , c | 76 ± 8 | 89 ± 8 a | 81 ± 6 a , b | 95 ± 10 a , b , c |
Home systolic BP, mmHg | 115 ± 10 | 121 ± 8 a | 132 ± 11 a , b | 139 ± 14 a , b , c | 112 ± 9 | 118 ± 8 a | 127 ± 10 a , b | 135 ± 14 a , b , c |
Home diastolic BP, mmHg | 74 ± 6 | 77 ± 6 a | 86 ± 6 a , b | 89 ± 9 a , b , c | 72 ± 5 | 74 ± 5 a | 83 ± 6 a , b | 87 ± 9 a , b , c |
Treated participants | ||||||||
Phenotypes | CH | WUCH | MUCH | SUCH | CH | WUCH | MUCH | SUCH |
N | 13 816 | 4,837 | 3,365 | 8,874 | 10 362 | 2,548 | 6,819 | 11 163 |
Men, n (%) | 34 | 36 a | 40 a , b | 40 a , b | 33 | 31 | 39 a , b | 40 a , b |
Age, years | 59 ± 14 | 61 ± 15 a | 61 ± 15 a | 62 ± 15 b | 60 ± 14 | 62 ± 14 a | 59 ± 15 b | 61 ± 15 a , b , c |
Body mass index, kg/m2 | 28.9 ± 5.2 | 28.6 ± 5 a | 28.9 ± 5 | 29.1 ± 5 b | 28.8 ± 5.2 | 28.2 ± 5.1 a | 29.2 ± 5 a , b | 29.1 ± 5.4 a , b |
Office systolic BP, mmHg | 119 ± 12 | 144 ± 14 a | 125 ± 10 a , b | 153 ± 19 a , b , c | 118 ± 12 | 145 ± 13 a | 123 ± 10 a , b | 151 ± 19 a , b , c |
Office diastolic BP, mmHg | 76 ± 8 | 89 ± 9 a | 79 ± 8 a , b | 94 ± 12 a , b , c | 75 ± 8 | 87 ± 9 a | 80 ± 7 a , b | 93 ± 11 a , b , c |
Home systolic BP, mmHg | 116 ± 10 | 122 ± 8 a | 135 ± 11 a , b | 143 ± 15 a , b , c | 114 ± 9 | 119 ± 8 a | 129 ± 11 a , b | 139 ± 16 a , b , c |
Home diastolic BP, mmHg | 73.5 ± 7 | 76 ± 6 a | 84 ± 7 a , b | 87 ± 10 a , b , c | 71 ± 6 | 72 ± 6 a | 82 ± 6 a , b | 86 ± 10 a , b , c |
The cutoff used to define abnormal office BP was 140/90 mmHg.
Abbreviations: BP, blood pressure; CH, controlled hypertension; HBPM, home blood pressure monitoring; MH, masked hypertension; MUCH, masked uncontrolled hypertension; NT, normotension; SH, sustained hypertension; SUCH, sustained uncontrolled hypertension; WH, white‐coat hypertension; WUCH, white‐coat uncontrolled hypertension.
p < .05 compared with participants with NT (among untreated participants) or CH (among treated participants) considering the same HBPM cutoff.
p < .05 compared with participants with WH (among untreated participants) or WUCH (among treated participants) considering the same HBPM cutoff.
p < .05 compared with participants with MH (among untreated participants) or MUCH (among treated participants) considering the same HBPM cutoff.